If you are interested in receiving email updates about program offerings, please click HERE to provide your contact information and be added to our mailing list.
Wednesday, March 1, 2024 @ 12pm - 1pm CT via Zoom
A review of the newest evidence for using COVID-19 therapeutics and a review of pipeline antivirals.
Featured On-Demand Programs
Community-acquired pneumonia (CAP) is a common infectious disease affecting all age groups. It occurs throughout the year but is more common in the fall and winter seasons. The treatment of CAP has evolved over the years based on new understandings of the causes and improved treatment options. This program will review the most current treatment recommendations regarding CAP.
Recorded Live @ Lunch - Chemotherapy, Biotherapy, and Radiotherapy Supportive Care: Essentials for Non-Oncology Pharmacist
This presentation aims to provide non-oncology pharmacists with an overview of chemotherapy, biotherapy, and radiotherapy supportive care. The objective is to equip pharmacists outside of the oncology setting with the necessary knowledge and skills to effectively support cancer patients undergoing these treatments. Evidence supporting the educational need includes the increasing complexity of cancer therapies and the potential for adverse events and drug interactions that require specialized management.
This webinar will focus on nonprescription medications used for self-care management of various conditions. The presentation will start with an overview of the laws associated with nonprescription medication approval. Next several medications which have recently undergone an Rx to OTC switch will be presented. Finally, the QuEST process for recommending OTC medications for patients will be summarized with participants being provided to practice the process through a patient case discussion.
Continuous glucose monitors (CGM) continue to gain use among people with diabetes. Pharmacists are uniquely positioned to help patients' selection of CGM to use and support the interpretation of the glucose data that is retrieved from CGMs, which ultimately can impact care. This webinar will compare differences between CGMs and traditional blood glucose monitoring, discuss differences among CGM products, and offer methods to analyze data downloads from CGMs.
This program is designed as an overview of the Alabama Medical Cannabis regulations. Best practices for practitioners who see patients receiving medical cannabis will be reviewed. A case activity will review the decision making for complex patients.
This preceptor development program was developed to educate and assist preceptors with effective precepting techniques, understanding statues and rules for preceptors in the state of AL, providing feedback on student performance, applying strategies for dealing with difficult learning situations and enhancing student preparation for licensing exams. Engaging material will include interactive lectures, group discussions, and real-world examples.
This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Preceptor licensure requirements.
This CE program will provide insight into managing type 2 diabetes in older adults. The presentation will focus on cardiorenal outcomes and drug therapy benefiting those outcomes.
Providing care for older adult patients requires many considerations for safe medication use. Several tools are available to help utilize the most appropriate medications in older adults. The American Geriatrics Society Beers Criteria is one of the most commonly utilized tools and has been updated in 2023. This presentation will review the changes made to the criteria and discuss the appropriate use of the criteria in practice.
Recorded Dual Antiplatelet Therapy in Acute Coronary Syndrome Following Percutaneous Coronary Intervention - Dr. Alyssa Osmonson
The use of dual antiplatelet therapy and its duration in acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) is rapidly evolving. This presentation will focus on reviewing current evidence and recommendations on the use of DAPT in ACS post-PCI, with a focus on duration.
This CE program will provide insight into managing postmenopausal osteoporosis. The presentation will focus on evidence-based recommendations based on patient-specific factors.
This presentation will provide an introduction to the fundamental principles of pharmacogenomics.